ClinicalTrials.govpublic full text
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
recurrent plasma cell myeloma, refractory plasma cell myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 230389
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.